
Results
2
Stocks where the price continues to rise after more than a year of consistent gains.
2 companies
ABIVAX Société Anonyme
Market Cap: €10.2b
A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€127.80
7D
58.8%
1Y
1,807.5%
Valerio Therapeutics Société anonyme
Market Cap: €184.8m
A clinical-stage biotechnology company, develops technology platforms dedicated to the targeted delivery of therapies.
ALVIO
€0.37
7D
85.4%
1Y
460.6%